Idexx Laboratories
IDXX
1,125 hedge funds and large institutions have $29.8B invested in Idexx Laboratories in 2024 Q4 according to their latest regulatory filings, with 166 funds opening new positions, 338 increasing their positions, 439 reducing their positions, and 141 closing their positions.
18% more first-time investments, than exits
New positions opened: 166 | Existing positions closed: 141
1% more funds holding
Funds holding: 1,116 → 1,125 (+9)
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
0.69% less ownership
Funds ownership: 88.5% → 87.82% (-0.69%)
19% less capital invested
Capital invested by funds: $36.7B → $29.8B (-$6.98B)
23% less repeat investments, than reductions
Existing positions increased: 338 | Existing positions reduced: 439
44% less call options, than puts
Call options by funds: $71.7M | Put options by funds: $129M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Flossbach Von Storch
Cologne,
Germany
|
+$204M |
| 2 |
Morgan Stanley
New York
|
+$198M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$166M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$162M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$139M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$692M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$425M |
| 3 |
BlackRock
New York
|
-$413M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$239M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$172M |
IDXX Hedge Fund Activity: Q4 2024 in Review
1,125 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2024, worth a combined $29.8B — down 19% from $36.7B a quarter earlier.
Buyers outnumbered sellers: 166 funds opened new IDXX positions and 141 closed out — a net gain of 25 holders — while 338 added to existing stakes and 439 trimmed.
The largest buyer was Flossbach Von Storch, adding an estimated $204M. The largest seller was AllianceBernstein, cutting an estimated $692M.
- 1,125 institutional investors held Idexx Laboratories (IDXX) as of Q4 2024, up from 1,116 in Q3 2024.
- Funds reported $29.8B of Idexx Laboratories stock for Q4 2024, down 19% quarter-over-quarter.
- 166 funds opened new Idexx Laboratories positions in Q4 2024 and 141 closed out, a net change of +25 holders.
- The largest Idexx Laboratories buyer in Q4 2024 was Flossbach Von Storch, an estimated $204M added.
- The largest Idexx Laboratories seller in Q4 2024 was AllianceBernstein, an estimated $692M sold.
Based on aggregated 13F filings for Q4 2024.